Duroflex Receives SEBI Approval for IPO Launch

Duroflex has received approval from the Securities and Exchange Board of India on January 21, 2026, to proceed with its proposed Initial Public Offer. The approval will remain valid for 12 months, allowing the company to move forward with subsequent regulatory and market‑linked steps.

The IPO launch timeline will depend on prevailing market conditions and completion of additional formalities required for public issuance. Key details such as the issue price band, IPO dates and lot size are expected to be announced in due course.

IPO Structure and Listing Plan

The Duroflex IPO will be executed as a Book Build Issue comprising 2 components. It includes a fresh issuance of shares worth ₹183.60 crore and an offer for sale of up to 2.26 crore equity shares by existing shareholders.

The company plans to list its equity shares on both NSE and BSE, subject to final approvals. JM Financial Ltd. will act as the book-running lead manager, while Kfin Technologies Ltd. will serve as the registrar to the issue. These roles form the core operational framework for the IPO process.

Company Background and Business Legacy

Duroflex Limited was incorporated in 1981, though its business heritage can be traced back to 1963 through its predecessor entity. The company operates within India’s sleep and comfort solutions industry, offering a diversified product portfolio.

Its legacy underscores decades of presence in the Indian consumer goods ecosystem, bridging traditional manufacturing with modern retail formats. Over the years, Duroflex has expanded its footprint through product innovation and multi‑channel distribution.

Product Portfolio and Manufacturing Capabilities

Duroflex manufactures foam, mattresses, sofas, recliners, beds, pillows, accessories and home furnishings. The company operates 7 technology‑enabled and vertically integrated manufacturing facilities located across India.

These facilities include in‑house foam production, which is the key raw material for several of its products, particularly mattresses and upholstered furniture. This integrated production capability helps the company maintain quality control and operational efficiency at scale.

Read More: SEBI Proposes Overhaul of KYC Norms to Ease Onboarding and Reduce Duplication.

Conclusion

Duroflex’s SEBI approval marks a significant milestone as it prepares to launch its IPO within the next 12 months. With a combination of fresh issuance and an OFS component, the planned listing represents a key step in strengthening its capital structure.

The company’s long operational legacy, vertically integrated manufacturing, diversified brand portfolio and extensive distribution network position it strongly within the sleep and comfort solutions industry. As market conditions evolve, further details on the IPO schedule and pricing will shape the next phase of Duroflex’s public market journey.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.